Britvic plc
19 December 2005
Britvic plc
19 December 2005
HOLDING(S) IN THE COMPANY
In accordance with Listing Rule 9.6.7, I hereby inform you that Britvic plc (the
'Company') was notified on 19 December 2005 pursuant to section 198 of the
Companies Act 1985, that the following entities have the following interests in
the Company:
AXA S.A. of 25 Avenue Matignon, 75008 Paris, France and its group companies, as
at 16 December 2005, were interested in 23,357,865 ordinary shares of 20p each
in the capital of the Company (the 'Ordinary Shares'), being represented by a
beneficial interest in 15,438,683 Ordinary Shares and a non-beneficial interest
of 7,919,182 Ordinary Shares, which represents 7.19% and 3.69% respectively of
the Company's issued share capital; and
The Goldman Sachs Group, Inc. of 85 Broad Street, New York, NY 10004, USA, as at
14 December 2005, had a beneficial interest in 11,168,186 Ordinary Shares, which
represents 5.19% of the Company's issued share capital.
John Price, Company Secretary
Britvic plc
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.